Efficacy and safety of cholesterol-lowering treatment - Reply

被引：5
作者：
Baigent, C
Keech, A
Kearney, P
Collins, R
Simes, J
机构：
[1] Clin Trial Serv Unit, Oxford OX3 7LF, England
[2] Epidemiol Studies Unit CTSU, Oxford OX3 7LF, England
[3] Univ Sydney, Natl Hlth & Med Res Council Clin Trials Ctr, Sydney, NSW 2006, Australia
来源：
LANCET | 2006年 / 367卷 / 9509期
关键词：
D O I：
10.1016/S0140-6736(06)68171-3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：470 / 471
页数：2
相关论文
共 5 条
[1]   Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention - The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study [J].
Athyros, VG ;
Papageorgiou, AA ;
Mercouris, BR ;
Athyrou, VV ;
Symeonidis, AN ;
Basayannis, EO ;
Demitriadis, DS ;
Kontopoulos, AG .
CURRENT MEDICAL RESEARCH AND OPINION, 2002, 18 (04) :220-228
[2]   Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins [J].
Baigent, C ;
Keech, A ;
Kearney, PM ;
Blackwell, L ;
Buck, G ;
Pollicino, C ;
Kirby, A ;
Sourjina, T ;
Peto, R ;
Collins, R ;
Simes, J .
LANCET, 2005, 366 (9493) :1267-1278
[3]  
Cozma L S, 2000, Heart, V84, pE3, DOI 10.1136/heart.84.2.e3
[4]   Drug prescriptions after acute myocardial infarction: Dosage, compliance, and persistence [J].
Simpson, E ;
Beck, C ;
Richard, H ;
Eisenberg, MJ ;
Pilote, L .
AMERICAN HEART JOURNAL, 2003, 145 (03) :438-444
[5]   Low prevalence of lipid lowering drug use in older men with established coronary heart disease [J].
Whincup, PH ;
Emberson, JR ;
Lennon, L ;
Walker, M ;
Papacosta, O ;
Thomson, A .
HEART, 2002, 88 (01) :25-29
1